- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07947420
Effect of Low Intensity Pulsed Ultrasound on Involution of the Uterus Postpartum
The aim of this study is to determine the effect of low intensity pulsed ultrasound on subinvolution of the uterus postpartum.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Low intensity pulsed ultrasound (LIPUS) is a safe and effective treatment for uterine involution. It contributes to uterine contraction after cesarean section, shortens the duration of lochia and relieves postpartum pain, thus decreasing the incidence of poor uterine involution, reducing vaginal bleeding and decreasing fundal height which was assessed using fundal level test. LIPUS can increase the frequency and amplitude of spontaneous contractions of the uterus in postpartum women. Therefore, this study will be conducted to investigate the effect of LIPUS on subinvolution through decreasing the incidence of delayed uterine atony and postpartum hemorrhage in postpartum women whether they had vaginal or cesarean delivery. There is no previous study illustrating the effect of LIPUS on subinvolution by using an objective measurement, so in this study, the effect of LIPUS will be measured using an evaluative ultrasonography. This study will add a new piece of information that maybe helpful for women suffering from this condition and may help the field of physical therapy for women health.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Mahitab M Yosri, PHD
- Numéro de téléphone: 01222606996
- E-mail: mahitab.yosri@pt.cu.edu.eg
Sauvegarde des contacts de l'étude
- Nom: Alaa H Ibrahim, Bachelor
- Numéro de téléphone: 01019209456
- E-mail: alaahisham197@gmail.com
Lieux d'étude
-
-
-
Tanta, Egypte
- Cairo university
-
Contact:
- Alaa H Ibrahim, Bachlor
- Numéro de téléphone: 01019209456
- E-mail: alaahisham197@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Postpartum women with uterine subinvolution (delivered vaginally or through caesarean section).
- All women are regularly lactating.
- Their age will be ranged from 25 to 40 years old.
- Their body mass index will be ranged from 20 - 30 kg/m².
Exclusion Criteria:
- History of abdominal surgeries except for cesarean section.
- Abdominal skin diseases, lesions, injuries, burns or open wounds.
- Any malignant tumors or fibroids.
- Coagulation disorders.
- History of chronic diseases such as diabetes, hypertension, cardiovascular and pulmonary diseases.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Postpartum exercise program group
The participant will follow a program of postpartum exercises, 30 minutes, 3 sessions / week for 6 weeks. |
The postpartum exercise program will begin with 6-minute warm up stretching exercises for hamstrings, hip adductors, gluteal muscles, quadriceps, calves and soleus. The main phase of exercise program will consist of core stabilization exercises, done for 10 repetition and repeated twice / day, total of 30 minutes, 3 sessions / week for 6 weeks. It will include abdominal breathing exercise, bridge exercises and kneeling abdominal exercises. |
|
Expérimental: Low intensity pulsed ultrasound and postpartum exercise program group
The participants will receive low intensity pulsed ultrasound with frequency 0.7-1.0 MHz for 30 minutes, 3 sessions / week for 6 weeks, in addition to the same program of postpartum exercises. |
The postpartum exercise program will begin with 6-minute warm up stretching exercises for hamstrings, hip adductors, gluteal muscles, quadriceps, calves and soleus. The main phase of exercise program will consist of core stabilization exercises, done for 10 repetition and repeated twice / day, total of 30 minutes, 3 sessions / week for 6 weeks. It will include abdominal breathing exercise, bridge exercises and kneeling abdominal exercises. The participants will receive therapeutic ultrasound using the following parameters: frequency 0.7-1 MHz, with intensity <3 W/cm2 for 30 min, 6 hours post vaginal delivery and 24 hours post cesarean section. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Uterine involution
Délai: 6 weeks
|
A diagnostic ultrasound device (EDAN, DUS 60, China), with 2.5-MHz convex transducer will be used to trace fundus level and progression of uterine involution before and after the intervention for all participants in both groups. |
6 weeks
|
|
Pain Intensity
Délai: 6 weeks
|
Visual analogue scale (VAS) will be used to assess pain intensity. It is a numeric scale, usually represents a horizontal line, 100 mm (10cm) in length, representing the severity of symptoms from 0 "no symptoms" to 10 "very severe symptoms . VAS is a valuable and reliable tool for the documentation of symptom severity, treatment effectiveness. |
6 weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Hossam H Kamel, Professor, Al-Azhar University
- Chaise d'étude: Hala M Omara, Professor, Cairo University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- P.T.REC/012/006454
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .